Insight into the regulation of axonal transport from the study of KIF1A-associated neurological disorder
- PMID: 36655764
- DOI: 10.1242/jcs.260742
Insight into the regulation of axonal transport from the study of KIF1A-associated neurological disorder
Abstract
Neuronal function depends on axonal transport by kinesin superfamily proteins (KIFs). KIF1A is the molecular motor that transports synaptic vesicle precursors, synaptic vesicles, dense core vesicles and active zone precursors. KIF1A is regulated by an autoinhibitory mechanism; many studies, as well as the crystal structure of KIF1A paralogs, support a model whereby autoinhibited KIF1A is monomeric in solution, whereas activated KIF1A is dimeric on microtubules. KIF1A-associated neurological disorder (KAND) is a broad-spectrum neuropathy that is caused by mutations in KIF1A. More than 100 point mutations have been identified in KAND. In vitro assays show that most mutations are loss-of-function mutations that disrupt the motor activity of KIF1A, whereas some mutations disrupt its autoinhibition and abnormally hyperactivate KIF1A. Studies on disease model worms suggests that both loss-of-function and gain-of-function mutations cause KAND by affecting the axonal transport and localization of synaptic vesicles. In this Review, we discuss how the analysis of these mutations by molecular genetics, single-molecule assays and force measurements have helped to reveal the physiological significance of KIF1A function and regulation, and what physical parameters of KIF1A are fundamental to axonal transport.
Keywords: Axonal transport; KAND; KIF1A; Kinesin; Synaptic vesicles; UNC-104.
© 2023. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interests The authors declare no competing or financial interests.
Similar articles
-
KIF1A-Associated Neurological Disorder: An Overview of a Rare Mutational Disease.Pharmaceuticals (Basel). 2023 Jan 19;16(2):147. doi: 10.3390/ph16020147. Pharmaceuticals (Basel). 2023. PMID: 37259299 Free PMC article. Review.
-
De novo mutations in KIF1A-associated neuronal disorder (KAND) dominant-negatively inhibit motor activity and axonal transport of synaptic vesicle precursors.Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2113795119. doi: 10.1073/pnas.2113795119. Epub 2022 Aug 2. Proc Natl Acad Sci U S A. 2022. PMID: 35917346 Free PMC article.
-
Motor domain-mediated autoinhibition dictates axonal transport by the kinesin UNC-104/KIF1A.PLoS Genet. 2021 Nov 29;17(11):e1009940. doi: 10.1371/journal.pgen.1009940. eCollection 2021 Nov. PLoS Genet. 2021. PMID: 34843479 Free PMC article.
-
Disease-associated mutations hyperactivate KIF1A motility and anterograde axonal transport of synaptic vesicle precursors.Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18429-18434. doi: 10.1073/pnas.1905690116. Epub 2019 Aug 27. Proc Natl Acad Sci U S A. 2019. PMID: 31455732 Free PMC article.
-
Breathing down the neck of Unc104.J Cell Biol. 2003 Nov 24;163(4):693-5. doi: 10.1083/jcb.200310137. J Cell Biol. 2003. PMID: 14638852 Free PMC article. Review.
Cited by
-
Neurons dispose of hyperactive kinesin into glial cells for clearance.EMBO J. 2024 Jul;43(13):2606-2635. doi: 10.1038/s44318-024-00118-0. Epub 2024 May 28. EMBO J. 2024. PMID: 38806659 Free PMC article.
-
A Model for Chemomechanical Coupling of Kinesin-3 Motor.Cell Mol Bioeng. 2024 Feb 18;17(2):137-151. doi: 10.1007/s12195-024-00795-1. eCollection 2024 Apr. Cell Mol Bioeng. 2024. PMID: 38737453
-
Presynaptic perspective: Axonal transport defects in neurodevelopmental disorders.J Cell Biol. 2024 Jun 3;223(6):e202401145. doi: 10.1083/jcb.202401145. Epub 2024 Apr 3. J Cell Biol. 2024. PMID: 38568173 Free PMC article. Review.
-
A plant flavonol and genetic suppressors rescue a pathogenic mutation associated with kinesin in neurons.Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2311936121. doi: 10.1073/pnas.2311936121. Epub 2024 Jan 25. Proc Natl Acad Sci U S A. 2024. PMID: 38271337
-
Comparative analysis of two Caenorhabditis elegans kinesins KLP-6 and UNC-104 reveals a common and distinct activation mechanism in kinesin-3.Elife. 2024 Jan 11;12:RP89040. doi: 10.7554/eLife.89040. Elife. 2024. PMID: 38206323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical